Spruce Biosciences (SPRB)
NASDAQ:SPRB
US Market
Holding SPRB?
Track your performance easily

Spruce Biosciences (SPRB) Income Statement

283 Followers

Spruce Biosciences Income Statement

Last quarter (Q2 2024), Spruce Biosciences's total revenue was $1.60M, a decrease of -27.27% from the same quarter last year. In Q2, Spruce Biosciences's net income was $-9.18M. See Spruce Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 9.47M$ 10.09M--$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
$ 9.50M$ 10.10M----
Operating Expense
$ 57.06M$ 62.08M$ 47.28M$ 42.07M$ 29.42M$ 13.11M
Operating Income
$ -47.49M$ -51.99M$ -47.28M$ -42.07M$ -29.42M$ -13.11M
Net Non Operating Interest Income Expense
$ 2.34M$ 4.07M$ 1.10M$ -226.00K$ -323.00K$ -65.00K
Other Income Expense
$ -2.04M-$ -750.00K$ -119.00K$ 200.00K$ 84.00K
Pretax Income
$ -43.18M$ -47.92M$ -46.18M$ -42.29M$ -29.54M$ -13.09M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -43.11M$ -47.92M$ -46.18M$ -42.29M$ -29.54M$ -13.09M
Basic EPS
$ -1.04$ -1.24$ -1.96$ -1.81$ -4.93$ -2.67
Diluted EPS
$ -1.04$ -1.24$ -1.96$ -1.81$ -4.93$ -2.67
Basic Average Shares
$ 163.85M$ 38.51M$ 23.53M$ 23.36M$ 5.99M$ 4.89M
Diluted Average Shares
$ 163.85M$ 38.51M$ 23.53M$ 23.36M$ 5.99M$ 4.89M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 57.06M$ 62.08M$ 47.28M$ 42.07M$ 29.42M$ 13.11M
Net Income From Continuing And Discontinued Operation
$ -43.11M$ -47.92M$ -46.18M$ -42.29M$ -29.54M$ -13.09M
Normalized Income
$ -28.54M$ -37.85M--$ -29.54M$ -13.09M
Interest Expense
----$ 323.00K$ 65.00K
EBIT
$ -43.16M$ -47.44M$ -45.76M$ -42.07M$ -29.22M$ -13.02M
EBITDA
$ -43.13M$ -47.37M$ -45.31M$ -41.56M$ -29.18M$ -13.01M
Currency in USD

Spruce Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis